ROCKET PHARMACEUTICALS INC's ticker is and the CUSIP is 77313F906. A total of 3 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $586 | +1.7% | 28,600 | -1.4% | 0.00% | – |
| Q2 2023 | $576 | +409.7% | 29,000 | +339.4% | 0.00% | – |
| Q1 2023 | $113 | -91.9% | 6,600 | -90.8% | 0.00% | -100.0% |
| Q4 2022 | $1,399 | -99.8% | 71,500 | +87.7% | 0.00% | +100.0% |
| Q3 2022 | $608,000 | +583.1% | 38,100 | +486.2% | 0.00% | – |
| Q2 2022 | $89,000 | +53.4% | 6,500 | +75.7% | 0.00% | – |
| Q1 2022 | $58,000 | -19.4% | 3,700 | +12.1% | 0.00% | – |
| Q4 2021 | $72,000 | -95.0% | 3,300 | -89.3% | 0.00% | -100.0% |
| Q3 2021 | $1,428,000 | +4.7% | 30,900 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $1,364,000 | +84.3% | 30,800 | +18343.1% | 0.00% | 0.0% |
| Q1 2021 | $740,000 | +335.3% | 167 | +438.7% | 0.00% | – |
| Q4 2020 | $170,000 | +1316.7% | 31 | +416.7% | 0.00% | – |
| Q2 2020 | $12,000 | -64.7% | 6 | -76.0% | 0.00% | – |
| Q1 2020 | $34,000 | -37.0% | 25 | +4.2% | 0.00% | – |
| Q4 2019 | $54,000 | +350.0% | 24 | +118.2% | 0.00% | – |
| Q3 2019 | $12,000 | +1100.0% | 11 | +1000.0% | 0.00% | – |
| Q2 2019 | $1,000 | -97.1% | 1 | -95.0% | 0.00% | – |
| Q1 2019 | $35,000 | +118.8% | 20 | -68.8% | 0.00% | -100.0% |
| Q1 2018 | $16,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 81,000 | $1,659,690 | 0.01% |
| JANE STREET GROUP, LLC | 384,200 | $7,872,258 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 28,600 | $586 | 0.00% |